These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31605775)

  • 1. Targeting USP9x/SOX2 axis contributes to the anti-osteosarcoma effect of neogambogic acid.
    Chen X; Zhang X; Cai H; Yang W; Lei H; Xu H; Wang W; Zhu Q; Kang J; Yin T; Gu W; Wu YL
    Cancer Lett; 2020 Jan; 469():277-286. PubMed ID: 31605775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.
    Lu Q; Lu D; Shao ZM; Li DQ
    Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.
    Cox JL; Wilder PJ; Gilmore JM; Wuebben EL; Washburn MP; Rizzino A
    PLoS One; 2013; 8(5):e62857. PubMed ID: 23667531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-Regulation of Ubiquitin-Specific Peptidase 9X Inhibited Proliferation, Migration and Invasion of Osteosarcoma via ERK1/2 and PI3K/Akt Signaling Pathways.
    Zheng W; Li S; Huang J; Dong Y; Zhang H; Zheng J
    Biol Pharm Bull; 2022; 45(9):1283-1290. PubMed ID: 36047196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sox2 is required for tumor development and cancer cell proliferation in osteosarcoma.
    Maurizi G; Verma N; Gadi A; Mansukhani A; Basilico C
    Oncogene; 2018 Aug; 37(33):4626-4632. PubMed ID: 29743593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells.
    Lu Q; Zhang FL; Lu DY; Shao ZM; Li DQ
    Cancer Med; 2019 Nov; 8(15):6730-6740. PubMed ID: 31512408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
    Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
    Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3.
    Chen W; Song J; Liu S; Tang B; Shen L; Zhu J; Fang S; Wu F; Zheng L; Qiu R; Chen C; Gao Y; Tu J; Zhao Z; Ji J
    J Biomed Sci; 2021 Jun; 28(1):44. PubMed ID: 34112167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics.
    Chen X; Lu D; Gao J; Zhu H; Zhou Y; Gao D; Zhou H
    J Proteome Res; 2019 Jun; 18(6):2654-2665. PubMed ID: 31059266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1-Sox2 axis.
    Zhang Y; Pan Y; Xie C; Zhang Y
    Cell Death Dis; 2018 Jul; 9(7):777. PubMed ID: 29991717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deubiquitinase USP9X regulates the invasion of prostate cancer cells by regulating the ERK pathway and mitochondrial dynamics.
    Zhang J; Wang J; Luan T; Zuo Y; Chen J; Zhang H; Ye Z; Wang H; Hai B
    Oncol Rep; 2019 Jun; 41(6):3292-3304. PubMed ID: 31002345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines.
    Li H; Zheng B
    Med Sci Monit; 2019 Jun; 25():4207-4216. PubMed ID: 31169265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
    Wang Z; Tan M; Chen G; Li Z; Lu X
    IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP9X destabilizes pVHL and promotes cell proliferation.
    Zhang C; Peng Z; Zhu M; Wang P; Du X; Li X; Liu Y; Jin Y; McNutt MA; Yin Y
    Oncotarget; 2016 Sep; 7(37):60519-60534. PubMed ID: 27517496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanoma.
    Potu H; Kandarpa M; Peterson LF; Durham A; Donato NJ; Talpaz M
    Oncotarget; 2021 Feb; 12(3):160-172. PubMed ID: 33613844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies.
    Peterson LF; Sun H; Liu Y; Potu H; Kandarpa M; Ermann M; Courtney SM; Young M; Showalter HD; Sun D; Jakubowiak A; Malek SN; Talpaz M; Donato NJ
    Blood; 2015 Jun; 125(23):3588-97. PubMed ID: 25814533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth.
    Pal A; Dziubinski M; Di Magliano MP; Simeone DM; Owens S; Thomas D; Peterson L; Potu H; Talpaz M; Donato NJ
    Neoplasia; 2018 Feb; 20(2):152-164. PubMed ID: 29248719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
    Chen Z; Wang HW; Wang S; Fan L; Feng S; Cai X; Peng C; Wu X; Lu J; Chen D; Chen Y; Wu W; Lu D; Liu N; You Y; Wang H
    J Clin Invest; 2019 Apr; 129(5):2043-2055. PubMed ID: 30958800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The deubiquitinase USP34 stabilizes SOX2 and induces cell survival and drug resistance in laryngeal squamous cell carcinoma.
    Dai WL; Yuan SX; Cao JP
    Kaohsiung J Med Sci; 2020 Dec; 36(12):983-989. PubMed ID: 32783291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP9X deubiquitinates and stabilizes CDC123 to promote breast carcinogenesis through regulating cell cycle.
    Song N; Deng L; Zeng L; He L; Liu C; Liu L; Fu R
    Mol Carcinog; 2023 Oct; 62(10):1487-1503. PubMed ID: 37314216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.